Crossmark

Nanoencapsulated methyl salicylate as a biorational alternative of synthetic antifungal and aflatoxin B1 suppressive agents

Crossref DOI link: https://doi.org/10.1007/s11356-019-05171-5

Published Online: 2019-05-02

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kujur, Anupam

Yadav, Amrita

Kumar, Akshay

Singh, Prem Pratap

Prakash, Bhanu
Funding

Funding for this research was provided by:

Science and Engineering Research Board (Science and Engineering Research Board (Scheme No. ECR/2016/000299) New Delhi, India)

CSIR (CSIR (JRF-Ref: 09/013(0706)/2017-EMR-I) New Delhi, India)
License Information

Text and Data Mining valid from 2019-05-02
More Information

Article History

Received: 22 January 2019

Accepted: 11 April 2019

First Online: 2 May 2019

Compliance with ethical standards

:

: The authors declare that there are no conflicts of interest.